-
1
-
-
0029083650
-
Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults
-
Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995, 92:785-789.
-
(1995)
Circulation
, vol.92
, pp. 785-789
-
-
Maron, B.J.1
Gardin, J.M.2
Flack, J.M.3
Gidding, S.S.4
Kurosaki, T.T.5
Bild, D.E.6
-
2
-
-
38349086961
-
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases
-
Elliott P., Andersson B., Arbustini E., Bilinska Z., Cecchi F., Charron P., et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008, 29:270-276.
-
(2008)
Eur Heart J
, vol.29
, pp. 270-276
-
-
Elliott, P.1
Andersson, B.2
Arbustini, E.3
Bilinska, Z.4
Cecchi, F.5
Charron, P.6
-
3
-
-
77952157390
-
Genetics of hypertrophic cardiomyopathy
-
Konno T., Chang S., Seidman J.G., Seidman C.E. Genetics of hypertrophic cardiomyopathy. Curr Opin Cardiol 2010, 25:205-209.
-
(2010)
Curr Opin Cardiol
, vol.25
, pp. 205-209
-
-
Konno, T.1
Chang, S.2
Seidman, J.G.3
Seidman, C.E.4
-
4
-
-
84860498637
-
Genetics of hypertrophic and dilated cardiomyopathy
-
Friedrich F.W., Carrier L. Genetics of hypertrophic and dilated cardiomyopathy. Curr Pharm Biotechnol 2012, 13:2467-2476.
-
(2012)
Curr Pharm Biotechnol
, vol.13
, pp. 2467-2476
-
-
Friedrich, F.W.1
Carrier, L.2
-
5
-
-
79952071913
-
Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities
-
Schlossarek S., Mearini G., Carrier L. Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities. J Mol Cell Cardiol 2011, 50:613-620.
-
(2011)
J Mol Cell Cardiol
, vol.50
, pp. 613-620
-
-
Schlossarek, S.1
Mearini, G.2
Carrier, L.3
-
7
-
-
81255179602
-
ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
-
Gersh B.J., Maron B.J., Bonow R.O., Dearani J.A., Fifer M.A., Link M.S., et al. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2011, 142:e153-e203.
-
(2011)
J Thorac Cardiovasc Surg
, vol.142
-
-
Gersh, B.J.1
Maron, B.J.2
Bonow, R.O.3
Dearani, J.A.4
Fifer, M.A.5
Link, M.S.6
-
8
-
-
78649929399
-
Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3
-
Oliva-Sandoval M.J., Ruiz-Espejo F., Monserrat L., Hermida-Prieto M., Sabater M., Garcia-Molina E., et al. Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3. Heart 2010, 96:1980-1984.
-
(2010)
Heart
, vol.96
, pp. 1980-1984
-
-
Oliva-Sandoval, M.J.1
Ruiz-Espejo, F.2
Monserrat, L.3
Hermida-Prieto, M.4
Sabater, M.5
Garcia-Molina, E.6
-
9
-
-
77949718853
-
Hypertrophic cardiomyopathy: from genetics to treatment
-
Marian A.J. Hypertrophic cardiomyopathy: from genetics to treatment. Eur J Clin Invest 2010, 40:360-369.
-
(2010)
Eur J Clin Invest
, vol.40
, pp. 360-369
-
-
Marian, A.J.1
-
10
-
-
67650086995
-
A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy
-
Friedrich F.W., Bausero P., Sun Y., Treszl A., Kramer E., Juhr D., et al. A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy. Eur Heart J 2009, 30:1648-1655.
-
(2009)
Eur Heart J
, vol.30
, pp. 1648-1655
-
-
Friedrich, F.W.1
Bausero, P.2
Sun, Y.3
Treszl, A.4
Kramer, E.5
Juhr, D.6
-
11
-
-
58149328530
-
Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations
-
Michels M., Soliman O.I., Kofflard M.J., Hoedemaekers Y.M., Dooijes D., Majoor-Krakauer D., et al. Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. JACC Cardiovasc Imaging 2009, 2:58-64.
-
(2009)
JACC Cardiovasc Imaging
, vol.2
, pp. 58-64
-
-
Michels, M.1
Soliman, O.I.2
Kofflard, M.J.3
Hoedemaekers, Y.M.4
Dooijes, D.5
Majoor-Krakauer, D.6
-
12
-
-
58449108642
-
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis
-
Cambronero F., Marin F., Roldan V., Hernandez-Romero D., Valdes M., Lip G.Y. Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis. Eur Heart J 2009, 30:139-151.
-
(2009)
Eur Heart J
, vol.30
, pp. 139-151
-
-
Cambronero, F.1
Marin, F.2
Roldan, V.3
Hernandez-Romero, D.4
Valdes, M.5
Lip, G.Y.6
-
13
-
-
33747195353
-
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
-
Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
-
(2006)
Cell
, vol.126
, pp. 663-676
-
-
Takahashi, K.1
Yamanaka, S.2
-
14
-
-
77957729169
-
Patient-specific induced pluripotent stem-cell models for long-QT syndrome
-
Moretti A., Bellin M., Welling A., Jung C.B., Lam J.T., Bott-Flugel L., et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010, 363:1397-1409.
-
(2010)
N Engl J Med
, vol.363
, pp. 1397-1409
-
-
Moretti, A.1
Bellin, M.2
Welling, A.3
Jung, C.B.4
Lam, J.T.5
Bott-Flugel, L.6
-
15
-
-
79952446402
-
Modelling the long QT syndrome with induced pluripotent stem cells
-
Itzhaki I., Maizels L., Huber I., Zwi-Dantsis L., Caspi O., Winterstern A., et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011, 471:225-229.
-
(2011)
Nature
, vol.471
, pp. 225-229
-
-
Itzhaki, I.1
Maizels, L.2
Huber, I.3
Zwi-Dantsis, L.4
Caspi, O.5
Winterstern, A.6
-
16
-
-
84860156650
-
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
-
Sun N., Yazawa M., Liu J., Han L., Sanchez-Freire V., Abilez O.J., et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med 2012, 4:130ra47.
-
(2012)
Sci Transl Med
, vol.4
-
-
Sun, N.1
Yazawa, M.2
Liu, J.3
Han, L.4
Sanchez-Freire, V.5
Abilez, O.J.6
-
17
-
-
84872026086
-
Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells
-
Lan F., Lee A.S., Liang P., Sanchez-Freire V., Nguyen P.K., Wang L., et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 2013, 12:101-113.
-
(2013)
Cell Stem Cell
, vol.12
, pp. 101-113
-
-
Lan, F.1
Lee, A.S.2
Liang, P.3
Sanchez-Freire, V.4
Nguyen, P.K.5
Wang, L.6
-
18
-
-
77954760209
-
Development of a drug screening platform based on engineered heart tissue
-
Hansen A., Eder A., Bonstrup M., Flato M., Mewe M., Schaaf S., et al. Development of a drug screening platform based on engineered heart tissue. Circ Res 2010, 107:35-44.
-
(2010)
Circ Res
, vol.107
, pp. 35-44
-
-
Hansen, A.1
Eder, A.2
Bonstrup, M.3
Flato, M.4
Mewe, M.5
Schaaf, S.6
-
19
-
-
80054783465
-
Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology
-
Schaaf S., Shibamiya A., Mewe M., Eder A., Stohr A., Hirt M.N., et al. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One 2011, 6:e26397.
-
(2011)
PLoS One
, vol.6
-
-
Schaaf, S.1
Shibamiya, A.2
Mewe, M.3
Eder, A.4
Stohr, A.5
Hirt, M.N.6
-
20
-
-
68249092692
-
Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice
-
Vignier N., Schlossarek S., Fraysse B., Mearini G., Kramer E., Pointu H., et al. Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice. Circ Res 2009, 105:239-248.
-
(2009)
Circ Res
, vol.105
, pp. 239-248
-
-
Vignier, N.1
Schlossarek, S.2
Fraysse, B.3
Mearini, G.4
Kramer, E.5
Pointu, H.6
-
21
-
-
84860522221
-
Increased myofilament Ca(2+) sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice
-
Fraysse B., Weinberger F., Bardswell S.C., Cuello F., Vignier N., Geertz B., et al. Increased myofilament Ca(2+) sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. J Mol Cell Cardiol 2012, 52:1299-1307.
-
(2012)
J Mol Cell Cardiol
, vol.52
, pp. 1299-1307
-
-
Fraysse, B.1
Weinberger, F.2
Bardswell, S.C.3
Cuello, F.4
Vignier, N.5
Geertz, B.6
-
22
-
-
57449095883
-
Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice
-
Baudenbacher F., Schober T., Pinto J.R., Sidorov V.Y., Hilliard F., Solaro R.J., et al. Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J Clin Invest 2008, 118:3893-3903.
-
(2008)
J Clin Invest
, vol.118
, pp. 3893-3903
-
-
Baudenbacher, F.1
Schober, T.2
Pinto, J.R.3
Sidorov, V.Y.4
Hilliard, F.5
Solaro, R.J.6
-
23
-
-
0027453927
-
Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments
-
Solaro R.J., Gambassi G., Warshaw D.M., Keller M.R., Spurgeon H.A., Beier N., et al. Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments. Circ Res 1993, 73:981-990.
-
(1993)
Circ Res
, vol.73
, pp. 981-990
-
-
Solaro, R.J.1
Gambassi, G.2
Warshaw, D.M.3
Keller, M.R.4
Spurgeon, H.A.5
Beier, N.6
-
24
-
-
4444368240
-
Roles of phosphorylation of myosin binding protein-C and troponin I in mouse cardiac muscle twitch dynamics
-
Tong C.W., Gaffin R.D., Zawieja D.C., Muthuchamy M. Roles of phosphorylation of myosin binding protein-C and troponin I in mouse cardiac muscle twitch dynamics. J Physiol 2004, 558:927-941.
-
(2004)
J Physiol
, vol.558
, pp. 927-941
-
-
Tong, C.W.1
Gaffin, R.D.2
Zawieja, D.C.3
Muthuchamy, M.4
-
25
-
-
37349023159
-
Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes
-
Pohlmann L., Kroger I., Vignier N., Schlossarek S., Kramer E., Coirault C., et al. Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes. Circ Res 2007, 101:928-938.
-
(2007)
Circ Res
, vol.101
, pp. 928-938
-
-
Pohlmann, L.1
Kroger, I.2
Vignier, N.3
Schlossarek, S.4
Kramer, E.5
Coirault, C.6
-
26
-
-
79960001856
-
Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease
-
de Lange W.J., Hegge L.F., Grimes A.C., Tong C.W., Brost T.M., Moss R.L., et al. Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease. Circ Res 2011, 109:8-19.
-
(2011)
Circ Res
, vol.109
, pp. 8-19
-
-
de Lange, W.J.1
Hegge, L.F.2
Grimes, A.C.3
Tong, C.W.4
Brost, T.M.5
Moss, R.L.6
-
27
-
-
84872236380
-
Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue
-
de Lange W.J., Grimes A.C., Hegge L.F., Ralphe J.C. Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue. J Gen Physiol 2013, 141:73-84.
-
(2013)
J Gen Physiol
, vol.141
, pp. 73-84
-
-
de Lange, W.J.1
Grimes, A.C.2
Hegge, L.F.3
Ralphe, J.C.4
-
28
-
-
84867679523
-
Increased afterload induces pathological cardiac hypertrophy: a new in vitro model
-
Hirt M.N., Sorensen N.A., Bartholdt L.M., Boeddinghaus J., Schaaf S., Eder A., et al. Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. Basic Res Cardiol 2012, 107:307.
-
(2012)
Basic Res Cardiol
, vol.107
, pp. 307
-
-
Hirt, M.N.1
Sorensen, N.A.2
Bartholdt, L.M.3
Boeddinghaus, J.4
Schaaf, S.5
Eder, A.6
-
29
-
-
44949259297
-
Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy
-
Olivotto I., Girolami F., Ackerman M.J., Nistri S., Bos J.M., Zachara E., et al. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Mayo Clin Proc 2008, 83:630-638.
-
(2008)
Mayo Clin Proc
, vol.83
, pp. 630-638
-
-
Olivotto, I.1
Girolami, F.2
Ackerman, M.J.3
Nistri, S.4
Bos, J.M.5
Zachara, E.6
-
30
-
-
72949085057
-
The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy
-
Carrier L., Schlossarek S., Willis M.S., Eschenhagen T. The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy. Cardiovasc Res 2010, 85:330-338.
-
(2010)
Cardiovasc Res
, vol.85
, pp. 330-338
-
-
Carrier, L.1
Schlossarek, S.2
Willis, M.S.3
Eschenhagen, T.4
-
31
-
-
0037155775
-
Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice
-
Harris S.P., Bartley C.R., Hacker T.A., McDonald K.S., Douglas P.S., Greaser M.L., et al. Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ Res 2002, 90:594-601.
-
(2002)
Circ Res
, vol.90
, pp. 594-601
-
-
Harris, S.P.1
Bartley, C.R.2
Hacker, T.A.3
McDonald, K.S.4
Douglas, P.S.5
Greaser, M.L.6
-
32
-
-
3142570567
-
Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice
-
Carrier L., Knoell R., Vignier N., Keller D.I., Bausero P., Prudhon B., et al. Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice. Cardiovasc Res 2004, 63:293-304.
-
(2004)
Cardiovasc Res
, vol.63
, pp. 293-304
-
-
Carrier, L.1
Knoell, R.2
Vignier, N.3
Keller, D.I.4
Bausero, P.5
Prudhon, B.6
-
33
-
-
47749102476
-
Cardiac myosin-binding protein C modulates the tuning of the molecular motor in the heart
-
Lecarpentier Y., Vignier N., Oliviero P., Guellich A., Carrier L., Coirault C. Cardiac myosin-binding protein C modulates the tuning of the molecular motor in the heart. Biophys J 2008, 95:720-728.
-
(2008)
Biophys J
, vol.95
, pp. 720-728
-
-
Lecarpentier, Y.1
Vignier, N.2
Oliviero, P.3
Guellich, A.4
Carrier, L.5
Coirault, C.6
-
34
-
-
2442698889
-
Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffening
-
Palmer B.M., Georgakopoulos D., Janssen P.M., Wang Y., Alpert N.R., Belardi D.F., et al. Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffening. Circ Res 2004, 94:1249-1255.
-
(2004)
Circ Res
, vol.94
, pp. 1249-1255
-
-
Palmer, B.M.1
Georgakopoulos, D.2
Janssen, P.M.3
Wang, Y.4
Alpert, N.R.5
Belardi, D.F.6
-
35
-
-
84880084828
-
Repair of Mybpc3 mRNA by 5'-trans-splicing in a mouse model of hypertrophic cardiomyopathy
-
Mearini G., Stimpel D., Kramer E., Geertz B., Braren I., Gedicke-Hornung C., et al. Repair of Mybpc3 mRNA by 5'-trans-splicing in a mouse model of hypertrophic cardiomyopathy. Mol Ther Nucleic Acids 2013, 2:e102.
-
(2013)
Mol Ther Nucleic Acids
, vol.2
-
-
Mearini, G.1
Stimpel, D.2
Kramer, E.3
Geertz, B.4
Braren, I.5
Gedicke-Hornung, C.6
|